Total Payments
$17,409
2024 Payments
$2,166
Companies
33
Transactions
1,011
Medicare Patients
1,857
Medicare Billing
$379,061
Payment Breakdown by Category
Food & Beverage$17,119 (98.3%)
Other$220.00 (1.3%)
Education$56.46 (0.3%)
Gifts$12.99 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,119 | 1,002 | 98.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 1.1% |
| Education | $56.46 | 6 | 0.3% |
| Debt forgiveness | $20.00 | 1 | 0.1% |
| Gift | $12.99 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $6,810 | 436 | $0 (2024) |
| QOL Medical, LLC | $2,066 | 106 | $0 (2024) |
| ABBVIE INC. | $1,098 | 56 | $0 (2024) |
| Braintree Laboratories, Inc. | $962.48 | 65 | $0 (2024) |
| Gilead Sciences, Inc. | $936.96 | 41 | $0 (2024) |
| Celgene Corporation | $600.83 | 57 | $0 (2024) |
| RedHill Biopharma Inc. | $434.28 | 31 | $0 (2023) |
| Concordia Pharmaceuticals Inc. | $413.46 | 20 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $363.72 | 18 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $362.88 | 17 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,166 | 113 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($1,197) |
| 2023 | $3,025 | 173 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($1,128) |
| 2022 | $2,987 | 163 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($972.14) |
| 2021 | $2,197 | 156 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($1,236) |
| 2020 | $1,559 | 102 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($898.66) |
| 2019 | $2,443 | 136 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($1,037) |
| 2018 | $1,446 | 83 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($341.08) |
| 2017 | $1,587 | 85 | Valeant Pharmaceuticals North America LLC ($362.88) |
All Payment Transactions
1,011 individual payment records from CMS Open Payments — Page 1 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $25.47 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.12 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.38 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: Gastroenterology | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Gastroenterology | ||||||
| 10/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.59 | General |
| 09/30/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.27 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 486 | 523 | $483,964 | $93,934 |
| 2022 | 8 | 513 | 564 | $481,595 | $107,412 |
| 2021 | 7 | 454 | 511 | $449,625 | $104,829 |
| 2020 | 9 | 404 | 451 | $411,600 | $72,886 |
Total Patients
1,857
Total Services
2,049
Medicare Billing
$379,061
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 116 | 118 | $212,400 | $34,855 | 16.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 69 | 72 | $129,600 | $23,650 | 18.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 34 | 34 | $64,600 | $14,161 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 112 | $28,000 | $8,395 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 62 | $18,649 | $6,977 | 37.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 53 | 53 | $16,800 | $4,609 | 27.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 47 | 53 | $13,250 | $1,128 | 8.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 19 | $665.00 | $159.60 | 24.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 122 | 127 | $228,600 | $45,513 | 19.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 66 | 73 | $116,800 | $26,258 | 22.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 25 | 25 | $47,500 | $10,727 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 101 | $25,787 | $8,182 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 57 | 70 | $21,100 | $8,128 | 38.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 68 | 68 | $21,208 | $6,846 | 32.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 71 | 80 | $19,900 | $1,699 | 8.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 20 | 20 | $700.00 | $59.28 | 8.5% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 108 | 108 | $194,400 | $37,642 | 19.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 79 | 82 | $131,200 | $29,428 | 22.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 101 | 138 | $34,461 | $11,397 | 33.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Office | 2021 | 25 | 25 | $47,500 | $11,140 | 23.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 76 | $22,800 | $9,125 | 40.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 62 | 62 | $18,564 | $6,038 | 32.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 20 | 20 | $700.00 | $60.00 | 8.6% |
| 45380 | Biopsy of large bowel using an endoscope | Office | 2020 | 95 | 98 | $176,400 | $27,209 | 15.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2020 | 45 | 47 | $75,200 | $15,735 | 20.9% |
About Dr. Hon-Ming Eng, MD
Dr. Hon-Ming Eng, MD is a Specialist healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477563385.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hon-Ming Eng, MD has received a total of $17,409 in payments from pharmaceutical and medical device companies, with $2,166 received in 2024. These payments were reported across 1,011 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($17,119).
As a Medicare-enrolled provider, Eng has provided services to 1,857 Medicare beneficiaries, totaling 2,049 services with total Medicare billing of $379,061. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location New York, NY
- Active Since 08/09/2006
- Last Updated 07/23/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477563385
Products in Payments
- XIFAXAN (Drug) $5,346
- Sucraid (Drug) $1,272
- SUCRAID (Drug) $794.18
- TRULANCE (Drug) $793.93
- PLENVU (Drug) $647.01
- ZEPOSIA (Drug) $585.17
- DUPIXENT (Biological) $416.50
- LINZESS (Drug) $388.58
- Donnatal (Drug) $348.94
- Talicia (Drug) $328.28
- SUPREP (Drug) $310.13
- Linzess (Drug) $309.83
- VIBERZI (Drug) $309.55
- INJECTAFER (Drug) $309.43
- CLENPIQ (Drug) $287.18
- MAVYRET (Drug) $229.39
- SUPREP BOWEL PREP (Drug) $223.52
- DIFICID (Drug) $214.85
- SUTAB (Drug) $205.20
- Mavyret (Drug) $184.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New York
Dr. Eric Rose, M.d, M.D
Specialist — Payments: $4.9M
Specialist $4.9M
Dr. Baron Lonner, M.d, M.D
Specialist — Payments: $2.9M
Specialist $2.9M
Dr. Richard Spaide, Md, MD
Specialist — Payments: $1.7M
Specialist $1.7M
Dr. Marla Dubinsky, M.d, M.D
Specialist — Payments: $1.6M
Specialist $1.6M
Mrs. Naomi Nakao, M.d, M.D
Specialist — Payments: $1.1M
Specialist $1.1M
Dr. Janice Dutcher, M.d, M.D
Specialist — Payments: $994,054
Specialist $994,054